Insider · CIK 0001814202
Ferneau Philip
Reports to the SEC for 1 company · BOSTON, MA
Transactions
7
Companies
1
Filings
6
CIK
0001814202
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-02 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-11 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-02-09 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-02-08 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-02-18 | CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-06-19 | CMPXCompass Therapeutics, Inc.P Purchase | +$320K |
| 2020-06-19 | CMPXCompass Therapeutics, Inc.P Purchase | +$1.25M |
Recent filings
- 4Ferneau Philip0001171843-26-000052SEC(opens sec.gov)
- 4Ferneau Philip0001171843-25-000827SEC(opens sec.gov)
- 4Ferneau Philip0001171843-24-000792SEC(opens sec.gov)
- 4Ferneau Philip0001171843-23-000853SEC(opens sec.gov)
- 4Ferneau Philip0000899243-22-007426SEC(opens sec.gov)
- 4Ferneau Philip0001213900-20-015637SEC(opens sec.gov)
Companies
Address
C/O COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601
BOSTON, MA, 02135